Intellia Therapeutics (NTLA) Shares Issued (2016 - 2026)

Intellia Therapeutics (NTLA) has 11 years of Shares Issued data on file, last reported at $750.0 million in Q1 2026.

• Shares Issued for Q1 2026 came in at $750.0 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $766.3 million (up 338.03% YoY), and the FY2025 annual result was $2.6 million, down 98.54% from the prior year.
• Shares Issued rose to $750.0 million in Q1 2026 per NTLA's latest filing, from $1.4 million in the prior quarter.
• Over five years, Shares Issued peaked at $750.0 million in Q1 2026 and troughed at -$386.7 million in Q2 2022.
• A 5-year average of $90.0 million and a median of $1.4 million in 2025 frame the typical range for Shares Issued.
• The sharpest annual moves came in 2022 and 2024: Shares Issued plunged 773.29% in 2022, then surged 17511.06% in 2024.
• A 5-year view of Shares Issued shows it stood at $398.9 million in 2022, then sank by 99.75% to $995000.0 in 2023, then surged by 17511.06% to $175.2 million in 2024, then sank by 99.23% to $1.4 million in 2025, then jumped by 55373.37% to $750.0 million in 2026.
• Business Quant data shows NTLA's Shares Issued at $750.0 million in Q1 2026, $1.4 million in Q4 2025, and $1.2 million in Q3 2025.